Conclusion:
Although possibly rare, we propose that carbamazepine should be
considered as a culprit for oropharyngeal dysphagia, especially in
patients with underlying neurologic disease. Due to carbamazepine’s
ability to inhibit neuronal depolarization, it is possible that these
medications can lead to increased oropharyngeal dysfunction in certain
patient populations. Clinicians should be aware of the existence of
carbamazepine-induced-dysphagia, especially when treating patients with
progressive neurologic disease and multiple comorbidities requiring
polypharmacy.